Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy

Gynecological Endocrinology

Volumn 27, Issue 9, 2011, Pages 701-705

  Darabi, Maryam ^a   Rabbani, Mohammed ^a   Ani, Mohsen ^a   Zarean, Elahe ^b   Panjehpour, Mojtaba ^a   Movahedian, Ahmad ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP binding cassette A1; HRT; lipoproteins; Post menopause

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LEUKOCYTE; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ATP-BINDING CASSETTE TRANSPORTERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LEUKOCYTES; LIPOPROTEINS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; POSTMENOPAUSE;

EID: 78650775572     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.507826     Document Type: Article

References (31)

1. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, Collins JA, van Dam M, Molhuizen HO, Loubste O. Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999;354:1341-1346. (Pubitemid 29481630)
2. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 2003;52:223-261.
3. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, Francone OL. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000;275:28634-28640.
4. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461. (Pubitemid 26269944)
5. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
6. Sullivan JM, Zwaag RV, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557-2562.
7. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 2003;19:55-72.
8. The Writing Group for the PEPI Trial, Miller VT, LaRosa J, Barnabei V, Kessler C, Levin G, Smith-Roth A, Griffin M, Stoy DB, Bush T. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1995;273:199-208.
9. Espeland MA, Marcovina SM, Miller V, Wood PD, Wasilauskas C, Sherwin R, Schrott H, Bush TL. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation 1998;97:979-986. (Pubitemid 28125470)
10. Lamon-Fava S, Postfai B, Diffenderfer M, DeLuca C, O'Connor J Jr, Welty FK, Dolnikowski GG, Barrett PH, Schaefer EJ. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol 2006;26:385-391. (Pubitemid 43732204)
11. Srivastava RA. Estrogen-induced regulation of the ATPbinding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem 2002;240:67-73. (Pubitemid 35385821)
12. Su YR, Dove DE, Major AS, Hasty AH, Boone B, Linton MF, Fazio S. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 2005;111:2373-2381. (Pubitemid 40647073)
13. Albrecht C, Soumian S, Amey JS, Sardini A, Higgins CF, Davies AH, Gibbs RG. ABCA1 expression in carotid atherosclerotic plaques. Stroke 2004;35:2801-2806. (Pubitemid 39565174)
14. Mohammad K, Sadat Hashemi SM, Farahani FK. Age at natural menopause in Iran. Maturitas 2004;49:321-326. (Pubitemid 39505186)
15. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, Aragaki AK, Aragaki SA, Brzyski RG, Brzyski AZ. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-1854. (Pubitemid 36532310)
16. Rifai N, Warnick G. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis C, Ashwood E, Bruns D, editors. Tietz textbook of clinical chemistry. Philadelphia: Elsevier Saunders; 2006. pp 903-968.
17. Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303: 1195-1198. (Pubitemid 11207583)
18. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
19. Gibbs RB. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocrinol Rev 2010;31:224-253.
20. Gass MLS, Bassuk SS, Manson JE. Reassessing benefits and risks of hormone therapy. Am J Lifestyle Med 2009;3:29-43.
21. Rijpkema AHM, van der Sanden AA, Ruijs AHC. Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas 1990; 12:259-285. (Pubitemid 20279933)
22. Sumino H, Ichikawa S, Itoh H, Utsugi T, Ohyama Y, Umeda M, Nakamura T, Kanda T, Mizunuma H, Tomono S. Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res 2003;60:134-142. (Pubitemid 37034403)
23. Loh FH, Chen LH, Yu SL, Jorgensen LN. The efficacy of two dosages of a continuous combined hormone replacement regimen. Maturitas 2002;41:123-131. (Pubitemid 34142501)
24. Wolfe BM, Barrett PH, Laurier L, Huff MW. Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women. J Lipid Res 2000;41:368-375. (Pubitemid 30183619)
25. Park JS, Jung HH, Yang WS, Kim SB, Min WK, Chi HS. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients. Nephrol Dial Transplant 2000;15:1835-1840.
26. Ulloa N, Arteaga E, Bustos P, Duran-Sandoval D, Schulze K, Castro G, Jauhiainen M, Fruchart JC, Calvo C. Sequential estrogen-progestin replacement therapy in healthy postmenopausal women: effects on cholesterol efflux capacity and key proteins regulating high-density lipoprotein levels. Metabolism 2002;51:1410-1417.
27. Schaefer EJ, Foster DM, Zech LA. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 1983;57: 262-267. (Pubitemid 13032472)
28. Ulloa N, Verdugo C, Rios M, Sepulveda J, Sepulveda S, Naveas R, Calvo C. Increased activity of lecithin:cholesterol acyltransferase during short-term oral estrogen progestin replacement therapy in a group of postmenopausal women. Metabolism 1998;47:297-300. (Pubitemid 28108777)
29. Jones DR, Schmidt RJ, Pickard RT, Foxworthy PS, Eacho PI. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J Lipid Res 2002;43:383-391. (Pubitemid 34252268)
30. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534. (Pubitemid 36951364)
31. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-1587. (Pubitemid 40807497)